Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion

Human papillomavirus (HPV) infection is associated with the vast majority of cervical cancer cases as well as with other anogenital cancers. PepCan is an investigational HPV therapeutic vaccine for treating cervical high-grade squamous intraepithelial lesions. The present study was performed to test...

Full description

Bibliographic Details
Main Authors: Rahul Ravilla MD, Hannah N. Coleman BS, Cheryl-Emiliane Chow PhD, Luisa Chan PhD, Barbara J. Fuhrman PhD, William W. Greenfield MD, Michael Scott Robeson PhD, Kathryn Iverson PhD, Horace Spencer MS, Mayumi Nakagawa MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2019-12-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/1534735419893063

Internet

https://doi.org/10.1177/1534735419893063

Similar Items